The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000152.5(GAA):c.768dup (p.Ile257fs)

CA502402648

556534 (ClinVar)

Gene: GAA
Condition: glycogen storage disease II
Inheritance Mode: Autosomal recessive inheritance
UUID: ae1dd2a3-8503-4f32-a62f-72c9de2ebc69
Approved on: 2023-03-10
Published on: 2023-03-10

HGVS expressions

NM_000152.5:c.768dup
NM_000152.5(GAA):c.768dup (p.Ile257fs)
NC_000017.11:g.80107632dup
CM000679.2:g.80107632dup
NC_000017.10:g.78081431dup
CM000679.1:g.78081431dup
NC_000017.9:g.75696026dup
NG_009822.1:g.11077dup
ENST00000302262.8:c.768dup
ENST00000302262.7:c.768dup
ENST00000390015.7:c.768dup
ENST00000570803.5:c.768dup
NM_000152.3:c.768dup
NM_001079803.1:c.768dup
NM_001079804.1:c.768dup
NM_000152.4:c.768dup
NM_001079803.2:c.768dup
NM_001079804.2:c.768dup
NM_001079803.3:c.768dup
NM_001079804.3:c.768dup

Likely Pathogenic

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Insufficient Evidence"
Met criteria codes 2
PM2_Supporting PVS1
Not Met criteria codes 1
PM3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Lysosomal Storage Disorders Variant Curation Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Lysosomal Diseases VCEP
The NM_000152.5:c.768dup (p.Ile257TyrfsTer73) variant in GAA is a frameshift variant predicted to cause a premature stop codon, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is not in gnomAD v2.1.1. (PM2_Supporting). The variant has been reported in a patient with Pompe disease but further details regarding the second variant and residual GAA activity are unavailable (PMID: 18425781). There is a ClinVar entry for this variant (Variation ID: 556534). The classification of this variant has been upgraded from Variant of Uncertain Significance to Likely Pathogenic based on the recommendations of the ClinGen Sequence Variant Interpretation Working Group, that a variant meeting PVS1 and PM2_Supporting is classified as Likely Pathogenic (https://clinicalgenome.org/site/assets/files/5182/pm2_-_svi_recommendation_-_approved_sept2020.pdf ). In summary, this variant meets the criteria to be classified as Likely Pathogenic for Pompe disease. GAA-specific ACMG/AMP criteria met, based on the specifications of the ClinGen Lysosomal Diseases VCEP (Specifications Version 2.0): PVS1, PM2_Supporting. (Classification approved by the ClinGen Lysosomal Diseases VCEP, March 10, 2023).
Met criteria codes
PM2_Supporting
This variant is not in gnomAD v2.1.1. (PM2_Supporting)
PVS1
The NM_000152.5:c.768dup (p.Ile257TyrfsTer73) variant in GAA is a frameshift variant predicted to cause a premature stop codon, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).
Not Met criteria codes
PM3
This variant was identified in a patient with Pompe disease (PMID 18425781). However, further details regarding the second variant and residual GAA activity are unavailable. Therefore, PM3 is not met at the current time.
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.